Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-07-24 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
科创板上市公司独立董事提名人声明与承诺-吴应宇
Regulatory Filings
2024-07-24 Chinese
南微医学科技股份有限公司第三届监事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a supervisory board meeting of 南微医学科技股份有限公司. It details the election of new supervisory board members, approval of equity incentive plans for a subsidiary, and decisions regarding the use of surplus raised funds. The document includes voting results and references compliance with company law and stock exchange listing rules. It is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or dividend notice. The content focuses on board/management decisions and changes, specifically related to the supervisory board and corporate governance matters. Therefore, the document fits best under Board/Management Information (MANG). The document length is short (1360 characters), but it contains substantive content about board resolutions, not just an announcement of a report publication or a regulatory filing. Hence, it is classified as MANG with high confidence.
2024-07-24 Chinese
南微医学科技股份有限公司关于召开2024年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2024 second extraordinary general meeting of shareholders for 南微医学科技股份有限公司. It includes information about the meeting date, voting methods, agenda items (mainly election of board members and supervisors), registration procedures, and voting instructions. There is no financial data or results reported, nor is it a transcript or presentation. It is not an announcement of voting results but a notice to shareholders about the meeting and the matters to be voted on. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides information to shareholders to request votes for meetings. The document length is over 5,000 characters and contains detailed meeting and voting information, not just a brief announcement or report publication. Therefore, the correct classification is PSI with high confidence.
2024-07-24 Chinese
南微医学科技股份有限公司关于控股子公司实施股权激励暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a related-party transaction involving a controlling subsidiary implementing an equity incentive plan. It details the shareholding changes, the approval process by the board and independent directors, and the financial and legal background of the transaction. There is no indication that this is a full financial report, audit report, or earnings release. It is not a regulatory certification or a report publication announcement. The content focuses on a capital/financing update related to equity incentive and shareholding changes within a subsidiary, which fits the Capital/Financing Update (CAP) category.
2024-07-24 Chinese
科创板上市公司独立董事候选人声明与承诺-吴应宇
Regulatory Filings
2024-07-24 Chinese
南微医学科技股份有限公司持股5%以上股东减持达到5%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a significant shareholder's reduction in shareholding percentage, specifically a shareholder holding more than 5% of the company's shares reducing their stake by 5%. It details the shareholder's information, the shareholding changes, and confirms that the changes do not affect control or governance. The document references a "简式权益变动报告书" (Simplified Equity Change Report) filed on the Shanghai Stock Exchange website. The content is focused on notifying the market and shareholders about the change in major shareholding levels, which fits the definition of a Major Shareholding Notification (MRQ). The document length is 2556 characters, which is typical for such announcements and not a full financial report or other types of filings. Therefore, the correct classification is MRQ.
2024-07-19 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.